Company profile for XOMA

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics. The Compa...
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics. The Company’s royalty-aggregator business model includes acquiring additional licenses to programs with third-party funding.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2200 Powell Street, Suite 310 Emeryville, CA 94608 (510) 204-7200
Telephone
Telephone
(510) 204-7200
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186116/7281/en/XOMA-Royalty-Reports-Third-Quarter-and-Year-to-Date-2025-Financial-Results-and-Highlights-Recent-Business-Achievements.html

GLOBENEWSWIRE
12 Nov 2025
Xoma And Lava Buyout Cools With Lower Offer
Xoma And Lava Buyout Cools With Lower Offer

17 Oct 2025

// FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/xoma-and-lava-cool-buyout-lowering-both-cash-offer-and-closing-conditions

FIERCE BIOTECH
17 Oct 2025

https://www.globenewswire.com/news-release/2025/10/02/3160726/7281/en/XOMA-Royalty-Extends-Tender-Offer-to-Acquire-LAVA-Therapeutics-N-V.html

GLOBENEWSWIRE
02 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3158434/0/en/LAVA-Therapeutics-to-Move-Extraordinary-General-Meeting-to-Early-November-2025.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/09/17/3151655/7281/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-HilleVax-Inc.html

GLOBENEWSWIRE
17 Sep 2025

https://www.fiercebiotech.com/biotech/xoma-adds-fading-mural-oncology-portfolio-struggling-biotechs

FIERCE BIOTECH
20 Aug 2025

ABOUT THIS PAGE

Contact XOMA and get a quotation

XOMA is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of CELL LINE (SOURCE, HISTORY AND GENERATION ) FOR SCH 900105 CONCENTRATE FOR INJECTION bulk offered by XOMA

Find a price of XOMA 3AB bulk offered by XOMA

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty